UROVANT SCIENCES LTD's ticker is UROV and the CUSIP is G9381B108. A total of 22 filers reported holding UROVANT SCIENCES LTD in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $1,610,000 | +93.3% | 99,876 | +11.9% | 0.00% | – |
| Q3 2020 | $833,000 | -5.1% | 89,246 | 0.0% | 0.00% | – |
| Q2 2020 | $878,000 | +15.7% | 89,246 | +8.3% | 0.00% | – |
| Q1 2020 | $759,000 | -69.3% | 82,371 | -48.3% | 0.00% | – |
| Q4 2019 | $2,470,000 | +210.7% | 159,312 | +89.7% | 0.00% | – |
| Q3 2019 | $795,000 | +18.3% | 83,962 | -1.2% | 0.00% | – |
| Q2 2019 | $672,000 | +71.9% | 84,996 | +118.3% | 0.00% | – |
| Q1 2019 | $391,000 | – | 38,943 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 157,480 | $1,583,000 | 1.24% |
| Sio Capital Management, LLC | 215,042 | $2,161,000 | 0.58% |
| Prosight Management, LP | 99,870 | $1,004,000 | 0.44% |
| Perceptive Advisors | 865,359 | $8,697,000 | 0.24% |
| Eventide Asset Management | 669,000 | $6,723,000 | 0.23% |
| Park West Asset Management LLC | 432,500 | $4,347,000 | 0.19% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1,385,000 | $13,919,000 | 0.04% |
| KORNITZER CAPITAL MANAGEMENT INC /KS | 51,100 | $514,000 | 0.01% |
| MILLENNIUM MANAGEMENT LLC | 539,889 | $5,426,000 | 0.01% |
| Weiss Multi-Strategy Advisers LLC | 15,000 | $151,000 | 0.00% |